Literature DB >> 20333431

Evidence-based guidelines for treatment of cervical cancer in Japan: Japan Society of Gynecologic Oncology (JSGO) 2007 edition.

Satoru Nagase1, Yoshiki Inoue, Naohiko Umesaki, Daisuke Aoki, Masatsugu Ueda, Hideki Sakamoto, Shigemitsu Kobayashi, Ryo Kitagawa, Takafumi Toita, Shoji Nagao, Kiyoshi Hasegawa, Ichio Fukasawa, Keiichi Fujiwara, Yoh Watanabe, Kiyoshi Ito, Hitoshi Niikura, Tsuyoshi Iwasaka, Kazunori Ochiai, Hidetaka Katabuchi, Toshiharu Kamura, Ikuo Konishi, Noriaki Sakuragi, Tadao Tanaka, Yasuo Hirai, Yuji Hiramatsu, Makio Mukai, Hiroyuki Yoshikawa, Tadao Takano, Kosuke Yoshinaga, Takeo Otsuki, Michiko Sakuma, Noriyuki Inaba, Yasuhiro Udagawa, Nobuo Yaegashi.   

Abstract

Clinical practice guidelines for gynecologic cancers have been published by the National Comprehensive Cancer Network and the National Cancer Institute. Whereas these guidelines form the basis for the standard of care for gynecologic malignancies in the United States, it has proven difficult to institute them in Japan due to differences in patient characteristics, health-care delivery systems, and insurance programs. Therefore, evidence-based guidelines for treating cervical cancer specifically in Japan have been under development. The Guidelines Formulation Committee and Evaluation Committee were independently established within the Committee for Treatment Guidelines for Cervical Cancer. Opinions from within and outside the Japan Society of Gynecologic Oncology (JSGO) were incorporated into the final draft, and the guidelines were published after approval by the JSGO. These guidelines are composed of ten chapters and comprise three algorithms. Each chapter consists of a clinical question, recommendations, background, objectives, explanations, and references. The objective of these guidelines is to clearly delineate the standard of care for cervical cancer treatment in Japan in order to ensure equitable care for all Japanese women diagnosed with cervical cancer.

Entities:  

Mesh:

Year:  2010        PMID: 20333431     DOI: 10.1007/s10147-010-0061-x

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  2 in total

1.  Impact of adoption of chemoradiotherapy on the outcome of cervical cancer in Ontario: results of a population-based cohort study.

Authors:  Robert Pearcey; Qun Miao; Weidong Kong; Jina Zhang-Salomons; William J Mackillop
Journal:  J Clin Oncol       Date:  2007-06-10       Impact factor: 44.544

2.  Current status of gynecologic cancer in Japan.

Authors:  Kimio Ushijima
Journal:  J Gynecol Oncol       Date:  2009-06-29       Impact factor: 4.401

  2 in total
  24 in total

1.  Questionnaire survey of the current status of radical trachelectomy in Japan.

Authors:  Shinya Sato; Daisuke Aoki; Hiroaki Kobayashi; Tsuyoshi Saito; Ryuichiro Nishimura; Tadayoshi Nagano; Nobuo Yaegashi; Takayuki Enomoto; Junzo Kigawa
Journal:  Int J Clin Oncol       Date:  2010-11-19       Impact factor: 3.402

2.  Japan Society of Gynecologic Oncology guidelines 2011 for the treatment of uterine cervical cancer.

Authors:  Yasuhiko Ebina; Nobuo Yaegashi; Hidetaka Katabuchi; Satoru Nagase; Yasuhiro Udagawa; Toru Hachisuga; Tsuyoshi Saito; Mikio Mikami; Yoichi Aoki; Hiroyuki Yoshikawa
Journal:  Int J Clin Oncol       Date:  2015-03-24       Impact factor: 3.402

3.  Survey of the clinical practice pattern of using sentinel lymph node biopsy in patients with gynecological cancers in Japan: the Japan Society of Gynecologic Oncology study.

Authors:  Shinichi Togami; Hiroaki Kobayashi; Hitoshi Niikura; Muneaki Shimada; Nobuyuki Susumu; Tomohito Tanaka; Yoshito Terai; Tomoyuki Nagai; Tsukasa Baba; Hideaki Yahata; Wataru Yamagami; Ken Yamaguchi; Tsuyoshi Yamashita; Nobuo Yaegashi; Hidetaka Katabuchi; Daisuke Aoki
Journal:  Int J Clin Oncol       Date:  2021-03-25       Impact factor: 3.402

4.  Cisplatin with dose-dense paclitaxel before and after radical hysterectomy for locally advanced cervical cancer: a prospective multicenter phase II trial with a dose-finding study.

Authors:  Maki Tanioka; Satoshi Yamaguchi; Muneaki Shimada; Shoji Nagao; Kazuhiro Takehara; Masato Nishimura; Satoshi Morita; Shunichi Negoro; Kiyoshi Fujiwara; Junzo Kigawa
Journal:  Med Oncol       Date:  2017-07-05       Impact factor: 3.064

5.  Radiotherapy quality assurance of the Japanese Gynecologic Oncology Group study (JGOG1066): a cooperative phase II study of concurrent chemoradiotherapy for uterine cervical cancer.

Authors:  Takafumi Toita; Shingo Kato; Satoshi Ishikura; Kayoko Tsujino; Takeshi Kodaira; Takashi Uno; Kazuo Hatano; Hideyuki Sakurai; Yuzuru Niibe; Tomoko Kazumoto; Tetsuo Nishimura; Ryo Kitagawa; Miki Fukutani; Masahiko Oguchi; Kenji Umayahara; Yasuyuki Hirashima; Yoichi Aoki; Ken Takizawa
Journal:  Int J Clin Oncol       Date:  2011-02-18       Impact factor: 3.402

6.  Clinical outcome of pelvic exenteration in patients with advanced or recurrent uterine cervical cancer.

Authors:  Sota Tanaka; Satoru Nagase; Michiko Kaiho-Sakuma; Tomoyuki Nagai; Hiroki Kurosawa; Masafumi Toyoshima; Hideki Tokunaga; Takeo Otsuki; Hiroki Utsunomiya; Tadao Takano; Hitoshi Niikura; Kiyoshi Ito; Nobuo Yaegashi
Journal:  Int J Clin Oncol       Date:  2013-02-13       Impact factor: 3.402

7.  Low-dose SN-38 with paclitaxel induces lethality in human uterine cervical adenocarcinoma cells by increasing caspase activity.

Authors:  Mizue Teramoto; Takahiro Suzuki; Seiro Satohisa; Yushi Akashi; Motoki Matsuura; Miwa Suzuki; Ryoichi Tanaka; Tsuyoshi Saito
Journal:  Med Mol Morphol       Date:  2013-03-16       Impact factor: 2.309

8.  Prognostic factors for patients with cervical cancer treated with concurrent chemoradiotherapy: a retrospective analysis in a Japanese cohort.

Authors:  Daisuke Endo; Yukiharu Todo; Kazuhira Okamoto; Shinichiro Minobe; Hidenori Kato; Noriaki Nishiyama
Journal:  J Gynecol Oncol       Date:  2014-10-13       Impact factor: 4.401

9.  Impact of concurrent chemotherapy on definitive radiotherapy for women with FIGO IIIb cervical cancer.

Authors:  Yuuki Kuroda; Naoya Murakami; Madoka Morota; Shuhei Sekii; Kana Takahashi; Koji Inaba; Hiroshi Mayahara; Yoshinori Ito; Ryo-Ichi Yoshimura; Minako Sumi; Yoshikazu Kagami; Noriyuki Katsumata; Takahiro Kasamatsu; Jun Itami
Journal:  J Radiat Res       Date:  2012-06-15       Impact factor: 2.724

10.  Permanent interstitial re-irradiation with Au-198 seeds in patients with post-radiation locally recurrent uterine carcinoma.

Authors:  Kaori Okazawa; Keiko Yuasa-Nakagawa; Ryo-Ichi Yoshimura; Hitoshi Shibuya
Journal:  J Radiat Res       Date:  2012-10-15       Impact factor: 2.724

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.